St. Ives

Description

St. Ives Green Tea & Bamboo Blackhead Cleansing Scrub is an emulsion formulated with salicylic acid. This product is designed to target blackheads and promote clearer skin. The inclusion of green tea and bamboo extracts contributes to its cleansing properties, enhancing the overall efficacy of the formulation.

Uses and Indications

This drug is indicated for the management of acne. It assists in maintaining clear skin by preventing the formation of new blackheads and acne blemishes.

Dosage and Administration

Healthcare professionals are advised to instruct patients to apply the scrub by squeezing an appropriate amount onto their fingertips. The product should be gently massaged onto damp skin using small circular motions. Following the application, the scrub should be thoroughly rinsed off to achieve optimal results.

For best outcomes, it is recommended that patients use the scrub 3 to 4 times per week. This frequency will help maintain skin health and enhance the desired effects.

Contraindications

There are no specific contraindications listed for this product. However, it is imperative to seek immediate medical assistance or contact a Poison Control Center if the product is swallowed.

Warnings and Precautions

For external use only. Healthcare professionals should advise patients that the likelihood of skin irritation and dryness increases when this product is used concurrently with other topical acne medications. In the event of irritation, it is recommended that patients limit their use to one topical acne medication at a time to mitigate adverse effects.

It is imperative to instruct patients to avoid contact with the eyes while using this product. Should contact occur, patients should rinse the affected area with water immediately to alleviate any discomfort.

In cases of accidental ingestion, patients must seek emergency medical assistance or contact a Poison Control Center without delay to ensure appropriate management.

Side Effects

Patients using this product should be aware that it is intended for external use only. The application of this topical medication may lead to skin irritation and dryness, particularly if used concurrently with another topical acne treatment. In such cases, it is advisable to limit the use to one topical acne medication at a time to minimize the risk of irritation.

Additionally, care should be taken to avoid contact with the eyes. If the product inadvertently comes into contact with the eyes, it is recommended to rinse thoroughly with water to alleviate any discomfort.

Drug Interactions

The concurrent use of this product with other topical acne medications may increase the risk of skin irritation and dryness. To mitigate these effects, it is advised that only one topical acne medication be used at a time. If irritation occurs, discontinuation of one of the products should be considered to alleviate symptoms. Monitoring for signs of skin irritation is recommended during the use of this product in conjunction with other topical treatments.

Packaging & NDC

Below are the non-prescription pack sizes of St. Ives (green tea and bamboo blackhead cleansing scrub). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Pediatric Use

Pediatric patients should be advised to keep this medication out of reach of children. In the event of accidental ingestion, immediate medical assistance should be sought, or contact with a Poison Control Center is recommended.

Geriatric Use

There is no specific information available regarding the use of this medication in geriatric patients, including dosage adjustments, safety concerns, or special precautions. Healthcare providers should exercise caution when prescribing this medication to elderly patients, as individual responses may vary. It is advisable to monitor these patients closely for any adverse effects or changes in efficacy, given the lack of targeted data for this population.

Pregnancy

There is no specific information available regarding the use of this medication during pregnancy, including safety concerns, dosage modifications, or special precautions. Healthcare professionals should consider the lack of data when prescribing this medication to pregnant patients. It is advisable to weigh the potential benefits against any unknown risks to fetal outcomes. Women of childbearing potential should be counseled on the importance of effective contraception during treatment.

Lactation

There are no specific warnings or recommendations regarding nursing mothers or lactation in the provided text. Therefore, healthcare professionals should consider the absence of data when advising lactating mothers about the use of this medication. It is advisable to monitor breastfed infants for any potential effects, although no specific concerns have been identified in the available information.

Renal Impairment

Patients with renal impairment have not been specifically addressed in the available prescribing information. There are no dosage adjustments, special monitoring requirements, or safety considerations outlined for individuals with reduced kidney function. Healthcare professionals should exercise caution and consider the lack of data when prescribing to this patient population.

Hepatic Impairment

Patients with hepatic impairment have not been specifically studied in relation to the use of this medication. Consequently, there are no established dosage adjustments, special monitoring requirements, or precautions for individuals with compromised liver function. It is recommended that healthcare providers exercise caution when prescribing this medication to patients with hepatic impairment, given the lack of data on its safety and efficacy in this population. Regular monitoring of liver function may be prudent in these cases, although specific parameters are not defined in the available information.

Overdosage

In the absence of specific information regarding overdosage, healthcare professionals are advised to exercise caution and adhere to general principles of management in cases of suspected overdose.

It is essential to monitor the patient closely for any potential symptoms that may arise, as the clinical presentation can vary depending on the substance involved and the individual patient's response. Common symptoms of overdose may include, but are not limited to, altered mental status, cardiovascular instability, respiratory distress, and gastrointestinal disturbances.

In the event of an overdose, immediate medical attention should be sought. Healthcare providers should initiate supportive care, which may include maintaining airway patency, providing supplemental oxygen, and monitoring vital signs. The use of activated charcoal may be considered if the patient presents within a suitable timeframe and if the ingestion was recent.

Furthermore, specific antidotes or treatments may be indicated based on the substance involved in the overdose. Consultation with a poison control center or a medical toxicologist is recommended to guide the management of the patient effectively.

Overall, vigilance and prompt intervention are critical in managing cases of suspected overdose, even in the absence of detailed information regarding specific overdosage effects.

Nonclinical Toxicology

No teratogenic or non-teratogenic effects have been reported in the available nonclinical studies. Additionally, there is no information regarding animal pharmacology and toxicology. The absence of data limits the assessment of potential risks associated with the compound in these areas.

Postmarketing Experience

No postmarketing experience details are available in the insert text.

Patient Counseling

Healthcare providers should advise patients to keep the medication out of reach of children to prevent accidental ingestion. It is important to emphasize that if the medication is swallowed, patients should seek medical help or contact a Poison Control Center immediately. This guidance is crucial for ensuring the safety and well-being of patients and their families.

Storage and Handling

The product is supplied in a container that must be kept tightly closed to maintain its integrity. It should be stored at room temperature, away from direct light to prevent degradation. Once opened, the product should be discarded to ensure safety and efficacy.

Additional Clinical Information

The product is administered topically and is recommended for use 3-4 times a week to achieve optimal results. It is intended for external use only, and patients should be advised that skin irritation and dryness may occur, particularly if another topical acne medication is used concurrently. In such cases, it is recommended to limit the use to one topical acne medication at a time.

Clinicians should counsel patients to avoid contact with the eyes and to rinse with water if contact occurs. Additionally, the product should be kept out of reach of children, and in the event of ingestion, medical assistance or contact with a Poison Control Center is advised.

Drug Information (PDF)

This file contains official product information for St. Ives, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)